Abstract:Young Woo Um, 1 Inwon Park, 1 Jae Hyuk Lee, 1 Hee Eun Kim, 1 Dongkwan Han, 1 Seung Hyun Kang, 1 Seonghye Kim, 1 You Hwan Jo 1– 3 1 Department of Emergency Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea; 2 Department of Emergency Medicine, Seoul National University College of Medicine, Seoul, Korea; 3 Disaster Medicine Research Center, Seoul National University Medical Research Center, Seoul, Korea Correspondence: Jae Hyuk Lee, Department of Emergency Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Korea, Tel +82-31-787-7579, Fax +82-31-787-4055, Email Purpose: Proper antibiotic administration is crucial for sepsis management. Given the escalating incidence of antimicrobial resistance, there is a pressing need for indicators of antimicrobial susceptibility with short turnaround times. This study aimed to investigate the potential of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as an early biomarker for in vivo antibiotic susceptibility in patients with sepsis. Patients and Methods: We conducted a retrospective analysis of plasma samples from patients enrolled in a pre-established study designed to investigate prognostic biomarkers in patients with sepsis or septic shock. Baseline and 6 h sTREM-1 levels were examined using enzyme-linked immunosorbent assays. The primary outcome of the study was the comparison of percentage changes in sTREM-1 levels at the 6 h relative to baseline with respect to antibiotic susceptibility. Results: Of the 596 patients enrolled in the pre-established study, 29 with a median age of 75.8 and a 28-day mortality rate of 17.2% were included in the present analysis. Among these patients, 24 were classified into the susceptible group, whereas the remaining five were classified into the resistant group. The trend in plasma sTREM-1 levels differed with respect to antibiotic susceptibility. Moreover, percentage change in sTREM-1 levels at the 6 h relative to baseline was significantly higher in the resistant group ( P = 0.028). Conclusion: The trend in plasma sTREM-1 levels in patients with sepsis differed with respect to antibiotic susceptibility, with a higher percentage change in patients treated with inappropriate antibiotics. These findings indicate the potential utility of sTREM-1 as an early biomarker of antibiotic susceptibility. Keywords: anti-bacterial agents, biomarkers, drug resistance, sepsis, triggering receptor expressed on myeloid cells-1 Timely and appropriate administration of antibiotics is crucial in sepsis management to improve patient survival. 1–3 Confirming the pathogen and its antimicrobial susceptibility is essential for achieving this objective. While blood culture is the gold standard for pathogen identification, 4,5 its extended turnaround times and potential failure to detect slow-growing pathogens pose significant limitations. 6,7 Furthermore, a significant proportion of sepsis cases yields negative blood culture results, 8,9 further restricting its clinical utility in guiding antibiotic selection. 8 Moreover, global rise in antimicrobial resistance adds complexity to antibiotic selection. 10 Therefore, development of rapid and accurate techniques for pathogen identification and susceptibility testing are imperative. 6,11 Additionally, there is a need for biomarkers that reflect the patient's response to antibiotics, aiding clinical decision-making alongside microbiological tests. 12,13 Although, several biomarkers have been explored for assessing treatment response in sepsis, 14–16 most rely on daily measurements, lacking time-related advantages compared to blood culture tests. Furthermore, our understanding of host biomarkers for treatment response, particularly concerning in vivo antibiotic susceptibility, remains limited. A previous study investigated dynamic alterations in hemodynamics and plasma biomarkers with respect to antibiotic susceptibility in a porcine model of bacteremia. 17 While there were no significant differences in hemodynamics and other biomarkers, the plasma level of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) exhibited significant differences in relation to antibiotic susceptibility over time. TREM-1 is a transmembrane receptor of the immunoglobulin superfamily that is mainly expressed on myeloid cells and is upregulated during infections. 18,19 Based on these findings, the authors proposed that sTREM-1 could potentially serve as a biomarker for in vivo antibiotic s -Abstract Truncated-

Expression Pattern of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Mice with Acinetobacter Baumannii Colonization and Infection in the Lung.

Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in lower respiratory tract infections: a meta-analysis.

[The Expression of Triggering Receptor Expressed on Myeloid Cells Receptor-1 in Aspergillus Infected Mice].

Expression of Triggering Receptor-1 in Myeloid Cells of Mice with Acute Lung Injury.

Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance.

Advance of TREM-1 and Its Role in Sepsis

Expression of Triggering Receptor Expressed on Myeloid Cells-1 in Lung Tissue of Rats with Acute Lung Injury Induced by Lipopolysaccharide and Its Relationship with Endoplasmic Reticulum Stress and Inflammatory Response

Trem-1 As A Potential Therapeutic Target in Neonatal Sepsis

Serum soluble triggering receptor expressed on myeloid cell-1 in the diagnosis of sepsis

Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a meta-analysis

Activation of triggering receptor expressed on myeloid cells-1 protects monocyte from apoptosis through regulation of myeloid cell leukemia-1.

Soluble Triggering Receptor Expressed on Myeloid Cells-1 As a Diagnostic Marker of Ventilator-Associated Pneumonia in Patients with Acute Ischemic Stroke

Diagnostic Value of the Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Bacterial Infection: a Meta-Analysis

The Prognostic Value of Serum Soluble TREM-1 on Outcome in Adult Patients with Sepsis

Diagnostic Performance of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Ventilator-Associated Pneumonia of Patients with Ischemic Stroke.

Dynamic Changes in Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis with Respect to Antibiotic Susceptibility

Expression and significance of TREM-1 in neonatal rats with intrauterine infection

Clinical value of soluble triggering receptor expressed on myeloid cells-1 in early diagnosis of ventilator-associated pneumonia and evaluation of prognosis

TREM-1 Signaling Promotes Host Defense During the Early Stage of Infection with Highly Pathogenic Streptococcus Suis

Soluble triggering receptor expressed on myeloid cells-1 as a useful biomarker for diagnosing ventilator-associated pneumonia after congenital cardiac surgery in children.

TREM1: A Positive Regulator for Inflammatory Response Via NF-κB Pathway in A549 Cells Infected with Mycoplasma Pneumoniae.